Commentary: Opioid impact fee will save lives in Delaware

I would like to correct misinformation in a recent op-ed Dover pharmacist Elizabeth Hauss penned about legislation that would hold pharmaceutical companies accountable for the opioid crisis they helped create here in Delaware. (“Delaware opioid surcharge plan ‘misguided’” April 17) Here are the facts: One in four Delaware families is now affected by this crisis. […]